Analyst Research

Report Title Price
Provider: Wright Reports
$75.00
Provider: New Constructs, LLC
$25.00
Provider: Thomson Reuters Stock Report
$25.00
Provider: ValuEngine, Inc.
$25.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Cardiovascular Systems, Inc. Issues Q1 2013 Guidance; Earnings Guidance Below Analysts' Estimates


Wednesday, 8 Aug 2012 04:00pm EDT 

Cardiovascular Systems, Inc. announced that for the first quarter of 2013, it expects revenue growth of 13% to 18% over the first quarter of 2012, to a range of $21.0 million to $22.0 million, net loss in the range of $(6.7) million to $(7.3) million, or loss per common share ranging from $(0.33) to $(0.36). According to I/B/E/S Estimates, analysts are expecting the Company to report revenue of $21.2 million, net income of $(4.3) and EPS of $(0.24) for first quarter of 2013. 

Company Quote

28.3
1.6 +5.99%
2:30pm EDT